Beneficiary name:

ImmunoGenes ABS Ltd.

A project title:

Development and validation of new types of COVID-19 specific laboratory assays (detection of coronavirus-specific RNA and antibodies) for institutional testing in an institutional pilot study

Grant amount of the contract:

41 437 440 Ft

Amount of support:

80 %

Project completion date:

2023.03.31

Project identification number:

2020-1.1.6-JÖVŐ-2021-00005

Fund:

National Research Development and Innovation Office NKFIA infoblokk kerettel program allo 2019 EN

Country:

Hungary

A project content:

The aim of the tender is to develop high-throughput diagnostic methods for the detection of the COVID-19 epidemic SARS-CoV-2 virus and the antibody produced against it, which use domestically produced reagents. The antibodies required for the development are produced by ImmunoGenes-ABS Ltd.

Contact us

eger

We use HTTP cookies on our pages for better operation.